carteolol and betaxolol

carteolol has been researched along with betaxolol in 34 studies

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19905 (14.71)18.7374
1990's9 (26.47)18.2507
2000's15 (44.12)29.6817
2010's2 (5.88)24.3611
2020's3 (8.82)2.80

Authors

AuthorsStudies
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H1
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Hugues, FC; Le Jeunne, C; Munera, Y1
Collignon-Brach, J1
James, IM1
Pillunat, LE; Stodtmeister, R1
Zimmerman, TJ1
Becker, EJ; Chen, Z; DeSantis, L; Hester, RK; McLaughlin, M1
Frishman, WH; Fuksbrumer, MS; Tannenbaum, M1
Cassels-Brown, A; Diggory, P; Fernandez, C1
Hong, SJ; Wang, HZ; Wu, KY2
Araie, M; Nagahara, M; Tamaki, Y; Tomidokoro, A; Tomita, K1
Hayashi, E; Hayashi-Morimoto, R; Ishikawa, H; Sato, Y; Yoshitomi, T1
Melena, J; Osborne, NN; Wood, JP1
Chidlow, G; Melena, J; Osborne, NN1
Kijlstra, A; Mulder, M; van Beek, LM; van Haeringen, NJ1
Iga, T; Ito, K; Ohtani, H; Sawada, Y; Takayanagi, R; Tsuchiya, K; Yamada, Y1
Barnett, MF; Haybittle, J; Parker, V; Watson, PG1
Belcaro, GV; Cesarone, MR; De Sanctis, MT; Incandela, L; Laurora, G; Minicucci, R; Steigerwalt, RD1
Ishibashi, Y; Muto, T; Roy, S; Sato, T1
Clark, JI; Martin, RW; Vaezy, S; Zderic, V1
Fong, JC; Hong, SJ; Wang, HZ; Wu, KY1
Baudouin, C; Blondin, C; Cholley, B; Haeffner-Cavaillon, N; Hamard, P1
Ignat, F1
Ikeda, Y; Ishibashi, T; Kinoshita, S; Mori, K; Nakajima, N; Naruse, S1
Jia, L; Li, Z; Wu, J; Xiao, X1
Fůs, M; Lešták, J; Marešová, K; Weissová, I1
Barbeau, M; Beauchemin, C; Cui, AX; Harasymowycz, P; Jobin-Gervais, K; Lachaine, J; Mathurin, K; Royer, C1
Jedlowski, MF; Jedlowski, PM1

Reviews

5 review(s) available for carteolol and betaxolol

ArticleYear
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:11

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship

1988
Pharmacologic effects of beta-blocking agents used in the management of glaucoma.
    Survey of ophthalmology, 1989, Volume: 33 Suppl

    Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Propanolamines; Solubility; Timolol

1989
Topical ophthalmic beta blockers: a comparative review.
    Journal of ocular pharmacology, 1993,Winter, Volume: 9, Issue:4

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Drug Tolerance; Glaucoma; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Ophthalmic Solutions; Timolol

1993
Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
    Journal of clinical pharmacology, 1994, Volume: 34, Issue:8

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Levobunolol; Metipranolol; Ocular Hypertension; Timolol

1994
Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis.
    The British journal of ophthalmology, 2022, Volume: 106, Issue:5

    Topics: Amides; Antihypertensive Agents; Bayes Theorem; Betaxolol; Bimatoprost; Brimonidine Tartrate; Carteolol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Network Meta-Analysis; Ocular Hypertension; Prostaglandins A; Prostaglandins F, Synthetic; Timolol; Travoprost

2022

Trials

6 trial(s) available for carteolol and betaxolol

ArticleYear
Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.
    Clinical pharmacology and therapeutics, 1990, Volume: 47, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Carteolol; Female; Heart Rate; Humans; Isoproterenol; Male; Muscle, Smooth, Vascular; Myocardium; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Timolol

1990
Early visual field changes with beta-blocking agents.
    Survey of ophthalmology, 1989, Volume: 33 Suppl

    Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Drug Evaluation, Preclinical; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Propanolamines; Timolol; Visual Fields

1989
Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
    Age and ageing, 1996, Volume: 25, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Airway Resistance; Betaxolol; Blood Pressure; Carteolol; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Pulse; Spirometry; Sympathomimetics; Timolol

1996
Effects of topical adrenergic agents on tissue circulation in rabbit and human optic nerve head evaluated with laser speckle tissue circulation analyzer.
    Survey of ophthalmology, 1997, Volume: 42 Suppl 1

    Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Animals; Betaxolol; Blood Circulation; Blood Flow Velocity; Blood Pressure; Carteolol; Double-Blind Method; Hemorheology; Humans; Intraocular Pressure; Ophthalmic Solutions; Optic Disk; Propanolamines; Quinazolines; Rabbits

1997
A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
    The British journal of ophthalmology, 2001, Volume: 85, Issue:8

    Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Carteolol; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Linear Models; Male; Prospective Studies; Survival Analysis; Timolol; Trabeculectomy; Treatment Outcome; Visual Fields

2001
Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:2

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Betaxolol; Carteolol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Propanolamines; Prospective Studies; Prostaglandins F, Synthetic; Time Factors

2008

Other Studies

23 other study(ies) available for carteolol and betaxolol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs.
    Survey of ophthalmology, 1989, Volume: 33 Suppl

    Topics: Acetazolamide; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Optic Disk; Pilocarpine; Propanolamines; Timolol

1989
New topical beta-blockers for glaucoma.
    Drug and therapeutics bulletin, 1987, Aug-10, Volume: 25, Issue:16

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Metipranolol; Propanolamines

1987
The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery.
    Survey of ophthalmology, 1994, Volume: 38 Suppl

    Topics: Animals; Arteries; Betaxolol; Calcium; Carteolol; Ciliary Body; Iliac Artery; Muscle, Smooth, Vascular; Nitroprusside; Rabbits; Swine; Timolol; Vasoconstriction

1994
Effects of pilocarpine and other antiglaucoma drugs on cultured human Tenon's fibroblast cells.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1997, Volume: 13, Issue:1

    Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Cell Division; Cells, Cultured; Eye; Fibroblasts; Glaucoma; Humans; Levobunolol; Muscarinic Agonists; Pilocarpine; Thymidine; Timolol

1997
Effects of beta antagonists on mechanical properties in rabbit ciliary artery.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1999, Volume: 237, Issue:8

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Cholinergic Agonists; Ciliary Arteries; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoproterenol; Male; Muscle, Smooth, Vascular; Phenylephrine; Rabbits; Receptors, Adrenergic, alpha-1; Timolol; Vasoconstriction

1999
Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels.
    European journal of pharmacology, 1999, Aug-13, Volume: 378, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Binding, Competitive; Calcium Channels; Carteolol; Cerebral Cortex; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Membranes; Nitrendipine; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Stereoisomerism; Timolol; Tritium

1999
Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
    British journal of pharmacology, 2000, Volume: 130, Issue:4

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Batrachotoxins; Betaxolol; Binding, Competitive; Carteolol; Cerebral Cortex; Dose-Response Relationship, Drug; Kinetics; Levobunolol; Membranes; Propranolol; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Sodium Radioisotopes; Synaptosomes; Timolol; Tritium

2000
Topical ophthalmic beta blockers may cause release of histamine through cytotoxic effects on inflammatory cells.
    The British journal of ophthalmology, 2000, Volume: 84, Issue:9

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Basophils; Betaxolol; Carteolol; Cells, Cultured; Dose-Response Relationship, Drug; Histamine Release; Humans; L-Lactate Dehydrogenase; Leukocytes; Metipranolol; Timolol

2000
Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2001, Volume: 17, Issue:3

    Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Cardiovascular Diseases; Carteolol; Exercise; Forced Expiratory Volume; Heart; Heart Rate; Humans; Lung; Ophthalmic Solutions; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Respiration Disorders; Retrospective Studies; Timolol

2001
Ocular and retrobulbar blood flow in ocular hypertensives treated with topical timolol, betaxolol and carteolol.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2001, Volume: 17, Issue:6

    Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Betaxolol; Blood Flow Velocity; Carteolol; Ciliary Arteries; Humans; Middle Aged; Ocular Hypertension; Ophthalmic Artery; Retinal Artery; Timolol

2001
Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow.
    Current eye research, 2001, Volume: 23, Issue:4

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Blood Flow Velocity; Blood Pressure; Carteolol; Choroid; Ciliary Body; Eye; Heart Rate; Intraocular Pressure; Rabbits; Random Allocation; Regional Blood Flow; Retinal Vessels; Timolol; Vascular Resistance

2001
Ocular drug delivery using 20-kHz ultrasound.
    Ultrasound in medicine & biology, 2002, Volume: 28, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Carteolol; Cornea; Drug Delivery Systems; Epithelium; Models, Animal; Permeability; Rabbits; Timolol; Ultrasonics

2002
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2003, Volume: 19, Issue:3

    Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; Dose-Response Relationship, Drug; Epinephrine; Glaucoma; Glutamic Acid; Latanoprost; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Tumor Cells, Cultured

2003
In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system.
    Current eye research, 2003, Volume: 27, Issue:4

    Topics: Adrenergic beta-Antagonists; Benzalkonium Compounds; Betaxolol; Carteolol; Complement System Proteins; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Timolol

2003
[Neuroprotection and vasoprotection in glaucoma].
    Oftalmologia (Bucharest, Romania : 1990), 2004, Volume: 48, Issue:2

    Topics: Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Carteolol; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Neuroprotective Agents; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Treatment Outcome

2004
Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells.
    The Kaohsiung journal of medical sciences, 2007, Volume: 23, Issue:3

    Topics: Animals; Betaxolol; Carteolol; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Corneal; Glaucoma; L-Lactate Dehydrogenase; Levobunolol; Pilocarpine; Timolol

2007
Enantioseparation of chiral β-blockers using polynorepinephrine-coated nanoparticles and chiral capillary electrophoresis.
    Analytical and bioanalytical chemistry, 2019, Volume: 411, Issue:10

    Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Electrophoresis, Capillary; Equipment Design; Humans; Limit of Detection; Magnetics; Magnetite Nanoparticles; Metoprolol; Norepinephrine; Solid Phase Microextraction; Stereoisomerism

2019
Betaxolol, Brimonidin and Carteolol in the Therapy of Normal-Tension Glaucoma.
    Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 2020,Spring, Volume: 76, Issue:2

    Topics: Betaxolol; Carteolol; Evoked Potentials, Visual; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged

2020
Topical ophthalmic beta-blockers are associated with ocular pseudopemphigoid: A pharmacovigilance study of antiglaucoma medications utilising the FDA adverse event reporting system.
    The Australasian journal of dermatology, 2022, Volume: 63, Issue:2

    Topics: Adrenergic beta-Antagonists; Antiglaucoma Agents; Betaxolol; Carteolol; Humans; Irritants; Ophthalmic Solutions; Pharmacovigilance; Preservatives, Pharmaceutical

2022